A Case of Severe Cushing Syndrome due to Metastatic Adrenocortical Carcinoma Treated With Osilodrostat
Although osilodrostat is currently only approved for use in pituitary Cushing disease, we found it effective in off-label use to treat Cushing syndrome due to ACC. Using a block-and-replace treatment strategy was a practical intervention after development of adrenal insufficiency.
Authors
- Kathleen Ruddiman (ORCID: https://orcid.org/0009-0005-5721-1874)
- Alex K Bonnecaze (ORCID: https://orcid.org/0000-0002-9642-7222)
- Catherine Price (ORCID: https://orcid.org/0000-0001-7555-3855)
Institutions
- Sandhills Community College (US)
- FirstHealth of the Carolinas (US)
- Wake Forest University (US)
Publication Details
- Journal
- AACE Clinical Case Reports
- Published
- 2024-10-23
- DOI
- https://doi.org/10.1016/j.aace.2024.10.005
- Citations
- 2
- Primary Topic
- Adrenal and Paraganglionic Tumors
- Type
- article
- Field-Weighted Citation Impact
- 1.15